Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 2
2016 4
2017 7
2018 7
2019 3
2020 6
2021 9
2022 10
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Effect of influenza vaccination in patients with asthma.
Martínez-Baz I, Navascués A, Casado I, Portillo ME, Guevara M, Gómez-Ibáñez C, Burgui C, Ezpeleta C, Castilla J. Martínez-Baz I, et al. Among authors: casado i. CMAJ. 2021 Jul 26;193(29):E1120-E1128. doi: 10.1503/cmaj.201757. CMAJ. 2021. PMID: 34312165 Free PMC article.
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
Trobajo-Sanmartín C, Martínez-Baz I, Miqueleiz A, Fernández-Huerta M, Burgui C, Casado I, Baigorría F, Navascués A, Castilla J, Ezpeleta C. Trobajo-Sanmartín C, et al. Among authors: casado i. Microbiol Spectr. 2022 Apr 27;10(2):e0000822. doi: 10.1128/spectrum.00008-22. Epub 2022 Apr 12. Microbiol Spectr. 2022. PMID: 35412379 Free PMC article.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Baruch J, Denayer S, Seyler L, Domegan L, Launay O, Machado A, Burgui C, Vaikutyte R, Niessen FA, Loghin II, Husa P, Aouali N, Panagiotakopoulos G, Tolksdorf K, Horváth JK, Howard J, Pozo F, Gallardo V, Nonković D, Džiugytė A, Bossuyt N, Demuyser T, Duffy R, Luong Nguyen LB, Kislaya I, Martínez-Baz I, Gefenaite G, Knol MJ, Popescu C, Součková L, Simon M, Michelaki S, Reiche J, Ferenczi A, Delgado-Sanz C, Lovrić Makarić Z, Cauchi JP, Barbezange C, Van Nedervelde E, O'Donnell J, Durier C, Guiomar R, Castilla J, Jonikaite I, Bruijning-Verhagen PC, Lazar M, Demlová R, Wirtz G, Amerali M, Dürrwald R, Kunstár MP, Kissling E, Bacci S, Valenciano M; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above). Rose AM, et al. Euro Surveill. 2023 Nov;28(47):2300187. doi: 10.2807/1560-7917.ES.2023.28.47.2300187. Euro Surveill. 2023. PMID: 37997665 Free PMC article.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Niessen FA, Machado A, Launay O, Denayer S, Seyler L, Baruch J, Burgui C, Loghin II, Domegan L, Vaikutytė R, Husa P, Panagiotakopoulos G, Aouali N, Dürrwald R, Howard J, Pozo F, Sastre-Palou B, Nonković D, Knol MJ, Kislaya I, Luong Nguyen LB, Bossuyt N, Demuyser T, Džiugytė A, Martínez-Baz I, Popescu C, Duffy R, Kuliešė M, Součková L, Michelaki S, Simon M, Reiche J, Otero-Barrós MT, Lovrić Makarić Z, Bruijning-Verhagen PC, Gomez V, Lesieur Z, Barbezange C, Van Nedervelde E, Borg ML, Castilla J, Lazar M, O'Donnell J, Jonikaitė I, Demlová R, Amerali M, Wirtz G, Tolksdorf K, Valenciano M, Bacci S, Kissling E; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to the named authors). Rose AM, et al. Euro Surveill. 2023 Nov;28(47):2300186. doi: 10.2807/1560-7917.ES.2023.28.47.2300186. Euro Surveill. 2023. PMID: 37997666 Free PMC article.
Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022.
Castilla J, Lecea Ó, Martín Salas C, Quílez D, Miqueleiz A, Trobajo-Sanmartín C, Navascués A, Martínez-Baz I, Casado I, Burgui C, Egüés N, Ezpeleta G, Ezpeleta C. Castilla J, et al. Among authors: casado i. Euro Surveill. 2022 Aug;27(33):2200619. doi: 10.2807/1560-7917.ES.2022.27.33.2200619. Euro Surveill. 2022. PMID: 35983774 Free PMC article.
Detection of Respiratory Viruses in Deceased Persons, Spain, 2017.
Navascués A, Casado I, Pérez-García A, Aguinaga A, Martínez-Baz I, Floristán Y, Ezpeleta C, Castilla J. Navascués A, et al. Among authors: casado i. Emerg Infect Dis. 2018 Jul;24(7):1331-1334. doi: 10.3201/eid2407.180162. Emerg Infect Dis. 2018. PMID: 29912695 Free PMC article.
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
Martínez-Baz I, Miqueleiz A, Casado I, Navascués A, Trobajo-Sanmartín C, Burgui C, Guevara M, Ezpeleta C, Castilla J; Working Group for the Study of COVID-19 in Navarra. Martínez-Baz I, et al. Among authors: casado i. Euro Surveill. 2021 May;26(21):2100438. doi: 10.2807/1560-7917.ES.2021.26.21.2100438. Euro Surveill. 2021. PMID: 34047271 Free PMC article.
64 results